'New Delhi' superbug unfairly named, admits editor

Jan 12, 2011

The naming of a drug-resistant superbug after New Delhi unfairly stigmatised India, the editor of the medical journal that first published research into the disease has admitted.

The journal revealed in August the discovery of a that could pose a global threat like (SARS) or human .

Researchers named the enzyme "New Delhi metallo-beta-lactamase 1 (NDM-1)" as some victims had recently travelled to India for medical treatment and cosmetic surgery -- but health experts in India were furious at the tag.

"It was an error of judgement," Richard Horton, editor of the London-based Lancet told reporters on Tuesday during a visit to Delhi. "We didn't think of its implications for which I sincerely apologise."

The name "unnecessarily stigmatised a single country and city" and should be changed by researchers, he added.

Indian doctors complained the name incorrectly suggested New Delhi was the origin of the bug -- and some politicians saw a conspiracy designed to scupper the country's booming health tourism industry.

The government health ministry angrily dismissed The Lancet's report as exaggerated and unfair, and publicly complained about the name.

The NDM-1 gene was first identified in 2009 by Cardiff University's Timothy Walsh in two types of bacteria -- Klebsiella pneumoniae and -- in a Swedish patient admitted to hospital in India.

After The Lancet article, cases were reported in Canada, the United States, Belgium, the Netherlands, Austria, France, Germany, Kenya, Australia, Hong Kong and Japan.

Horton said he stood by the study's research.

India has been criticised in the past for having a loose policy on the use of antibiotics, with the result that they are over-prescribed and over-used to the point where become more common.

Explore further: Were clinical trial practices in East Germany questionable?

add to favorites email to friend print save as pdf

Related Stories

France eyes tests for NDM-1 superbug

Aug 17, 2010

France will start screening patients for the NDM-1 bacterium, an antibiotic-resistant superbug that has unleashed a health scare, a medical watchdog said on Tuesday.

Japan confirms its first case of new superbug gene

Sep 07, 2010

(AP) -- Japan has confirmed the nation's first case of a new gene in bacteria that allows the microorganisms to become drug-resistant superbugs, detected in a man who had medical treatment in India, a Health Ministry offic ...

Recommended for you

Were clinical trial practices in East Germany questionable?

Oct 23, 2014

Clinical trials carried out in the former East Germany in the second half of the 20th century were not always with the full knowledge or understanding of participants with some questionable practices taking place, according ...

Schumacher's doctor sees progress after injury

Oct 23, 2014

A French physician who treated Michael Schumacher for nearly six months after the Formula One champion struck his head in a ski accident says he is no longer in a coma and predicted a possible recovery within three years.

User comments : 2

Adjust slider to filter visible comments by rank

Display comments: newest first

Squirrel
not rated yet Jan 12, 2011
It was understood after the naming of the Marburg virus that no more infectious agents were to be named after their locations as this might impair the readiness with which they are reported. Richard Horton and the Lancet should be ashamed and ask that in all further reporting that the bacteria be called the Richard Horton superbug.
iknow
not rated yet Jan 12, 2011
err? Wasn't there an article just last week confirming its origin in New Delhi and its correct naming?

hey ho